Cynthia Bamdad
Minerva Biotechnologies (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Cancer Research and Treatments, Advanced biosensing and bioanalysis techniques, Pluripotent Stem Cells Research
Most-Cited Works
- → A Self-Assembled Monolayer for the Binding and Study of Histidine-Tagged Proteins by Surface Plasmon Resonance(1996)494 cited
- → Contact with a component of the polymerase II holoenzyme suffices for gene activation(1995)265 cited
- → MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells(2009)94 cited
- → MUC1* Mediates the Growth of Human Pluripotent Stem Cells(2008)77 cited
- → A Minimal Fragment of MUC1 Mediates Growth of Cancer Cells(2008)75 cited
- → A Minimal Set of RNA Polymerase II Transcription Protein Interactions(1996)67 cited
- → A DNA Self-Assembled Monolayer for the Specific Attachment of Unmodified Double- or Single-Stranded DNA(1998)63 cited
- → A Primitive Growth Factor, NME7AB, Is Sufficient to Induce Stable Naïve State Human Pluripotency; Reprogramming in This Novel Growth Factor Confers Superior Differentiation(2016)27 cited
- → MUC1* Ligand, NM23-H1, Is a Novel Growth Factor That Maintains Human Stem Cells in a More Naïve State(2013)26 cited
- → A Gold Nanoparticle Platform for Protein–Protein Interactions and Drug Discovery(2011)24 cited